Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Vascular Health and Risk Management Volume 11, 2015 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study

Charles Saab1 Department of Endocrinology and Metabolism, Sacre Coeur University Hospital, Baabda, Lebanon

Feryal A Al-Saber2 Endocrine Department, Bahrain Defence Force Hospital, Rifaa, Bahrain

Jihad Haddad3 Division of Endocrinology Department of Internal Medicine, Prince Hamaza Hospital, Amman, Jordan

Mahir Khalil Jallo4 Department of Internal Medicine, Gulf Medical University, Ajman, United Arab Emirates

Habib Steitieh5 New Mowasat Hospital, Safat, Kuwait

Giovanni Bader6 Novartis Pharma AG, Basel, Switzerland

Mohamed Ibrahim7 Novartis Pharma Services AG, Dubai, United Arab EmiratesCorrespondence[email protected]

show all

Pages 149-155 | Published online: 24 Feb 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Salah Shelbaya & Sameh Rakha. (2017) Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt – results from the GUARD study. Current Medical Research and Opinion 33:5, pages 797-801.
Read now

Articles from other publishers (1)

Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee & Byung-Wan Lee. (2017) Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study). Journal of Diabetes Research 2017, pages 1-8.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references